Stocks Health care ELMD
NYSE · Health careElectromed, Inc. (ELMD)
Electromed, Inc. reported revenue of $73.8M in fiscal 2026, up 15.3% from a year earlier. Net income was $11.3M, a net margin of 15.3%. Operating cash flow minus capital spending left $8.4M of free cash flow in fiscal 2026. At June 30, 2026 it held $20.5M in cash. Its latest periodic report to the SEC is the annual report (10-K) filed on August 25, 2026.
Key facts about Electromed, Inc.
- Net worth
- Electromed, Inc. has a market value (market cap) of $225.1M at the latest share price, and shareholders' equity of $54M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2026 revenue was $73.8M (+15.3% year on year), with net income of $11.3M.
- Cash flow
- In fiscal 2026 operations brought in $9.7M of cash; after $1.3M of capital spending, free cash flow was $8.4M.
- Latest report
- The latest periodic report (annual report, 10-K) was filed with the SEC on August 25, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Electromed, Inc.'s next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What Electromed, Inc. does
Electromed, Inc. is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on NYSE under the ticker ELMD.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $73.8M | $11.3M | $1.30 | $8.4M |
| 2025 | $64M | $7.5M | $0.85 | $11.1M |
| 2024 | $54.7M | $5.2M | $0.58 | $8.8M |
| 2023 | $48.1M | $3.2M | $0.36 | -$333K |
| 2022 | $41.7M | $2.3M | $0.26 | -$2.1M |
| 2021 | $35.8M | $2.4M | $0.27 | $2.8M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where ELMD ranks in Health care
Latest SEC filings
What Electromed, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 29, 2026Proxy statement DEF 14A
- September 29, 2026Additional proxy material DEFA14A
- September 29, 2026
- August 25, 2026
- August 25, 2026Annual report 10-K · period to June 30, 2026Revenue rose 15% to $73.8M versus the prior year; diluted EPS $1.30 versus $0.85.
- May 29, 2026
- May 12, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 18% to $18.6M versus the same quarter last year; diluted EPS $0.35 versus $0.21.
- May 12, 2026
- March 26, 2026Passive stake changed SCHEDULE 13G/A
- February 10, 2026Quarterly report 10-Q · period to December 31, 2025Revenue rose 16% to $18.9M versus the same quarter last year; diluted EPS $0.32 versus $0.22.
What is ELMD worth? A DCF from its reported cash flow
Insider trades
What the people running Electromed, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 3 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 1, 2026 | Cunniff James L.CEO and President, Director | Shares withheld for tax | 2,671 | $72.4K |
| September 1, 2026 | Nagel Bradley M.Chief Financial Officer | Received as pay | 4,900 | - |
| September 1, 2026 | Nagel Bradley M.Chief Financial Officer | Shares withheld for tax | 1,102 | $29.9K |
| June 30, 2026 | Nagel Bradley M.Chief Financial Officer | Shares withheld for tax | 674 | $28.5K |
| June 8, 2026 | Cunniff James L.CEO and President, Director | Exercised options | 9,700 | $167.3K |
| June 8, 2026 | Cunniff James L.CEO and President, Director | Sold | 7,003 | $253.9K |
| June 8, 2026 | Cunniff James L.CEO and President, Director | Sold | 1,671 | $61.5K |
| June 8, 2026 | Cunniff James L.CEO and President, Director | Sold | 1,026 | $38.8K |
Who owns ELMD
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Dr. George H. Winn13G, passive with 2 related filers | 6.1% | November 13, 2024 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 128 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| J.E. Simmons & Co., P.C. | 483,822 | -9,000 |
| BlackRock, Inc. | 465,619 | +6,774 |
| Vanguard Capital Management LLC | 283,232 | -51,796 |
| Punch & Associates Investment Management, Inc. | 218,520 | -6,000 |
| Geode Capital Management, LLC | 217,115 | +15,222 |
| Dimensional Fund Advisors LP | 180,447 | +2,177 |
| Two Sigma Investments, LP | 167,492 | -36,108 |
| Gamco Investors, Inc. ET AL | 142,000 | 0 |
| State Street Corp | 112,616 | +6,253 |
| Renaissance Technologies LLC | 99,704 | -24,300 |
| Lazard Asset Management LLC | 93,472 | -1,741 |
| Vanguard Portfolio Management LLC | 84,297 | +5,960 |
| Northern Trust Corp | 84,138 | -8,150 |
| Goldman Sachs Group Inc | 72,704 | +195 |
| White Pine Capital LLC | 70,000 | -65,228 |
| Arrowstreet Capital, Limited Partnership | 66,798 | +17,367 |
| Bridgeway Capital Management, LLC | 57,563 | -7,000 |
| Invesco Ltd. | 51,394 | new |
| Vanguard Fiduciary Trust Co | 49,731 | +2,109 |
| Bank of New York Mellon Corp | 46,022 | +1,766 |
Insiders
9 insiders reported holding 323,281 shares in total, about $8.8M at the last price.
| Holder | Shares |
|---|---|
| Cunniff James L.CEO and President, Director | 145,080 |
| Erickson Stan K.Director | 38,817 |
| Skarvan KathleenDirector | 35,622 |
| Nagel Bradley M.Chief Financial Officer | 22,762 |
| Fluet GregoryDirector | 21,000 |
| Walsh Andrea M.Director | 18,000 |
| Galatowitsch Joseph L.Director | 15,000 |
| Tune Kathleen ADirector | 15,000 |
| Summers AndrewDirector | 12,000 |
Questions about ELMD
What does Electromed, Inc. do?
Electromed, Inc. is a company in the Health care sector, listed on NYSE as ELMD. Its shares trade on NYSE under the ticker ELMD.
What is Electromed, Inc.'s net worth?
Electromed, Inc. has a market value (market cap) of $225.1M at the latest share price, and shareholders' equity of $54M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Electromed, Inc. profitable?
Yes. In fiscal 2026 it reported net income of $11.3M on revenue of $73.8M, a net margin of 15.3%.
How much revenue does Electromed, Inc. make?
In fiscal 2026 Electromed, Inc. reported revenue of $73.8M. That is 15.3% more than a year earlier.
When did Electromed, Inc. last report?
Its most recent periodic report is the annual report (10-K) filed on August 25, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the proxy statement from September 29, 2026.
When is Electromed, Inc.'s next earnings report?
Electromed, Inc.'s next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare ELMD with
Follow ELMD
Get an email when Electromed, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Electromed, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.